MedTrace Logo

Potassium Supplementation to Reduce Blood Pressure

NCT05412654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-04-04

No results posted yet for this study

Summary

The aim of this study is to conduct a definitive trial to assess the efficacy of consuming 1L/day of water rich in potassium to reduce blood pressure in mild to moderately hypertensive adults. The objective is to assess the potential effect of the intervention on reducing systolic blood pressure. This study will comprise of a 4 week, double-blind, parallel randomised controlled trial. Participants will be adults with systolic blood pressure measurements of 130mmHg or greater. The intervention comprises advice to consume bottled water rich in potassium. The comparator will be regular bottled mineral water.This study will recruit 40 people with elevated systolic blood pressure (≥130mmHg) who are not regularly taking antihypertensive medication.

Conditions

  • Prehypertension

Interventions

DIETARY_SUPPLEMENT

High potassium water

High potassium water Potassium 6.2 mg/100ml

DIETARY_SUPPLEMENT

Control low potassium water

Control water Potassium 0.2 mg/100ml

Sponsors & Collaborators

  • Suntory Beverage & Food Limited

    collaborator UNKNOWN

  • Oxford Brookes University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-30
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05412654 on ClinicalTrials.gov